Status:
UNKNOWN
Study for the Clinical Roadmap and Prognosis of Pulmonary Artery Sarcoma.
Lead Sponsor:
China-Japan Friendship Hospital
Collaborating Sponsors:
The First Affiliated Hospital of Guangzhou Medical University
Beijing Chao Yang Hospital
Conditions:
Pulmonary Artery Sarcoma
Eligibility:
All Genders
Brief Summary
This is an observational study in which patients with pulmonary artery sarcoma were followed up for at least 36 months and survival was investigated.
Detailed Description
This is an observational study covering mainland China, and patients with pulmonary artery sarcoma were followed up for at least 36 months and survival was investigated.
Eligibility Criteria
Inclusion
- Computed tomography pulmonary angiography indicated that there were intraluminal defects
- Malignant histopathology was sarcoma
- Informed consent form was signed
Exclusion
- Life expectancy was less than 3 months due to diseases other than pulmonary artery sarcoma
- Expected inability to complete follow-up
Key Trial Info
Start Date :
December 31 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2025
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06165718
Start Date
December 31 2022
End Date
June 30 2025
Last Update
December 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
China-Japan Friendship Hospital
Beijing, Beijing Municipality, China, 100029